Neoadjuvant programmed cell death 1 inhibitor before liver transplantation for HCC is not associated with increased graft loss

Immune checkpoint inhibitors (ICIs) may lead to rejection and even graft loss of solid organ transplant recipients, making them not widely used in transplant patients. There is insufficient clinical experience in using ICIs as a bridging or downstaging therapy before transplantation. We performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tielong, Chen, Zhitao, Liu, Yao, Jia, Yu, Ju, Weiqiang, Chen, Maogen, Zhao, Qiang, Wang, Dongping, Guo, Zhiyong, Tang, Yunhua, He, Xiaoshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles: Hepatobiliary Malignancies and Transplant Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174104/
https://www.ncbi.nlm.nih.gov/pubmed/36747346
http://dx.doi.org/10.1097/LVT.0000000000000083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174104/
https://www.ncbi.nlm.nih.gov/pubmed/36747346
http://dx.doi.org/10.1097/LVT.0000000000000083

Ejemplares similares